IN THE UNITED STATES DISTRICT COURT

KELLYN CLAY,
  Plaintiff,

v.

UNITED STATES OF AMERICA,
by and through its agencies including but not limited to
the Central Intelligence Agency (CIA), Department of Defense (DoD),
and Department of Justice (DOJ),

and

PALANTIR TECHNOLOGIES INC.,
a private defense contractor headquartered in Denver, Colorado,

and

AMAZON.COM, INC.,
a multinational e-commerce corporation headquartered in Seattle, Washington,

and

JOHN DOE CONTRACTING AGENCIES AND AFFILIATES,
whose names and identities are presently unknown,

and

WILLIAM ALTON CLAY,
individually and in his capacity as executor of the Estate of Eugenia Clay Head,
  Defendants.

⸻ 

PLAINTIFF’S FIRST SET OF REQUESTS FOR PRODUCTION TO DEFENDANT AMAZON

Preamble (Relevance Statement)
Plaintiff Kellyn Clay alleges that Amazon, in coordination with other Defendants, engaged in retaliatory medical sabotage and surveillance practices that impaired Plaintiff’s ability to speak. These requests seek production of records relating to supplement distribution, biometric data handling, and communications concerning suppression of expressive activity.

⸻

Requests for Production
	1.	Supplement Distribution Records
All internal documents, compliance files, and communications concerning the distribution of vitamin D3, testosterone, or other supplements that could affect vocal function, including safety assessments, adverse event monitoring, or side effect analyses.
	2.	Adverse Event Data
All consumer complaints, incident reports, or internal studies referencing speech impairment, throat constriction, or anaphylaxis in connection with supplements distributed through Amazon’s platforms.
	3.	Health and Biometric Data
All agreements, policies, and communications relating to Amazon Web Services’ storage, processing, or sharing of data concerning vocal capacity, speech impairments, or allergic reactions, whether directly tied to Plaintiff or to similar populations.
	4.	Retaliation-Related Analysis
All documents reflecting monitoring, analysis, or reporting of Plaintiff’s expressive activity (including online postings, speech, or dissenting activity), particularly where such analysis coincided with medical or supplement interventions.
	5.	Government and Contractor Coordination
All contracts, memoranda of understanding, or communications between Amazon and (a) Palantir Technologies, (b) the Minnesota Department of Health, or (c) federal agencies, regarding supplement distribution, health surveillance, or initiatives relating to speech, behavior, or expression.
	6.	Knowledge of Speech-Suppressing Effects
All internal research, risk assessments, or external correspondence that mention or evaluate the potential for vitamin D3, testosterone, or related compounds to contribute to vocal cord calcification, mineralization of muscle/fascia, or impairment of speech.
	7.	Narrative and Messaging
All communications, public-relations materials, or talking points concerning adverse effects of supplements that could impair speech, particularly where messaging was coordinated with government agencies, contractors, or Palantir Technologies.
